Atomistry » Iron » PDB 6nlk-6o6l » 6o3i
Atomistry »
  Iron »
    PDB 6nlk-6o6l »
      6o3i »

Iron in PDB 6o3i: Crystal Structure of Human IDO1 Bound to Navoximod (Nlg-919)

Enzymatic activity of Crystal Structure of Human IDO1 Bound to Navoximod (Nlg-919)

All present enzymatic activity of Crystal Structure of Human IDO1 Bound to Navoximod (Nlg-919):
1.13.11.52;

Protein crystallography data

The structure of Crystal Structure of Human IDO1 Bound to Navoximod (Nlg-919), PDB code: 6o3i was solved by S.F.Harris, A.Oh, with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:

Resolution Low / High (Å) 74.17 / 2.69
Space group P 21 21 21
Cell size a, b, c (Å), α, β, γ (°) 85.062, 90.224, 130.237, 90.00, 90.00, 90.00
R / Rfree (%) 21.6 / 26.4

Other elements in 6o3i:

The structure of Crystal Structure of Human IDO1 Bound to Navoximod (Nlg-919) also contains other interesting chemical elements:

Fluorine (F) 2 atoms

Iron Binding Sites:

The binding sites of Iron atom in the Crystal Structure of Human IDO1 Bound to Navoximod (Nlg-919) (pdb code 6o3i). This binding sites where shown within 5.0 Angstroms radius around Iron atom.
In total 2 binding sites of Iron where determined in the Crystal Structure of Human IDO1 Bound to Navoximod (Nlg-919), PDB code: 6o3i:
Jump to Iron binding site number: 1; 2;

Iron binding site 1 out of 2 in 6o3i

Go back to Iron Binding Sites List in 6o3i
Iron binding site 1 out of 2 in the Crystal Structure of Human IDO1 Bound to Navoximod (Nlg-919)


Mono view


Stereo pair view

A full contact list of Iron with other atoms in the Fe binding site number 1 of Crystal Structure of Human IDO1 Bound to Navoximod (Nlg-919) within 5.0Å range:
probe atom residue distance (Å) B Occ
A:Fe501

b:49.7
occ:1.00
FE A:HEM501 0.0 49.7 1.0
ND A:HEM501 2.0 49.8 1.0
NC A:HEM501 2.0 49.5 1.0
NB A:HEM501 2.0 49.3 1.0
NA A:HEM501 2.0 49.9 1.0
NE2 A:HIS346 2.1 48.9 1.0
N10 A:LKP502 2.1 47.4 1.0
C1D A:HEM501 2.9 50.1 1.0
C4D A:HEM501 3.0 50.0 1.0
C9 A:LKP502 3.0 47.5 1.0
C4B A:HEM501 3.0 49.6 1.0
C4C A:HEM501 3.0 49.8 1.0
C1B A:HEM501 3.0 49.7 1.0
CE1 A:HIS346 3.0 48.9 1.0
C1C A:HEM501 3.0 49.4 1.0
C4A A:HEM501 3.0 49.8 1.0
C1A A:HEM501 3.1 50.1 1.0
CD2 A:HIS346 3.1 49.5 1.0
C11 A:LKP502 3.3 48.4 1.0
CHD A:HEM501 3.3 50.5 1.0
CHA A:HEM501 3.4 50.5 1.0
CHC A:HEM501 3.4 50.2 1.0
CHB A:HEM501 3.4 50.2 1.0
ND1 A:HIS346 4.2 50.3 1.0
CG A:HIS346 4.2 49.3 1.0
C3D A:HEM501 4.2 50.7 1.0
C2D A:HEM501 4.2 50.4 1.0
C2C A:HEM501 4.2 50.0 1.0
C3C A:HEM501 4.2 50.1 1.0
N8 A:LKP502 4.2 46.1 1.0
C2A A:HEM501 4.3 50.6 1.0
C3A A:HEM501 4.3 50.4 1.0
C2B A:HEM501 4.3 49.8 1.0
C3B A:HEM501 4.3 50.0 1.0
C7 A:LKP502 4.4 47.5 1.0
CB A:ALA264 4.5 48.0 1.0

Iron binding site 2 out of 2 in 6o3i

Go back to Iron Binding Sites List in 6o3i
Iron binding site 2 out of 2 in the Crystal Structure of Human IDO1 Bound to Navoximod (Nlg-919)


Mono view


Stereo pair view

A full contact list of Iron with other atoms in the Fe binding site number 2 of Crystal Structure of Human IDO1 Bound to Navoximod (Nlg-919) within 5.0Å range:
probe atom residue distance (Å) B Occ
B:Fe501

b:56.4
occ:1.00
FE B:HEM501 0.0 56.4 1.0
NA B:HEM501 1.9 56.6 1.0
N10 B:LKP502 1.9 45.5 1.0
NC B:HEM501 2.0 56.3 1.0
ND B:HEM501 2.0 56.5 1.0
NB B:HEM501 2.0 56.2 1.0
NE2 B:HIS346 2.2 61.7 1.0
C9 B:LKP502 2.8 45.2 1.0
C4A B:HEM501 3.0 56.6 1.0
C1D B:HEM501 3.0 56.8 1.0
C4D B:HEM501 3.0 56.8 1.0
C4C B:HEM501 3.0 56.5 1.0
C1C B:HEM501 3.0 56.2 1.0
C1A B:HEM501 3.0 56.8 1.0
C1B B:HEM501 3.0 56.6 1.0
C4B B:HEM501 3.1 56.5 1.0
C11 B:LKP502 3.1 45.5 1.0
CE1 B:HIS346 3.1 61.5 1.0
CD2 B:HIS346 3.3 61.9 1.0
CHB B:HEM501 3.4 57.0 1.0
CHA B:HEM501 3.4 57.2 1.0
CHD B:HEM501 3.4 57.2 1.0
CHC B:HEM501 3.4 56.9 1.0
N8 B:LKP502 4.1 46.2 1.0
C7 B:LKP502 4.2 46.1 1.0
C3A B:HEM501 4.2 57.1 1.0
C2A B:HEM501 4.2 57.2 1.0
C2C B:HEM501 4.2 56.8 1.0
C3C B:HEM501 4.2 56.8 1.0
CB B:ALA264 4.3 53.3 1.0
C3D B:HEM501 4.3 57.2 1.0
ND1 B:HIS346 4.3 62.5 1.0
C2D B:HEM501 4.3 57.2 1.0
C2B B:HEM501 4.3 56.7 1.0
C3B B:HEM501 4.3 57.0 1.0
CG B:HIS346 4.4 60.9 1.0

Reference:

S.Kumar, J.P.Waldo, F.A.Jaipuri, A.Marcinowicz, C.Van Allen, J.Adams, T.Kesharwani, X.Zhang, R.Metz, A.J.Oh, S.F.Harris, M.R.Mautino. Discovery of Clinical Candidate (1R,4R)-4-((R)-2-((S)-6-Fluoro-5H-Imidazo[5, 1-A]Isoindol-5-Yl)-1-Hydroxyethyl)Cyclohexan-1-Ol (Navoximod), A Potent and Selective Inhibitor of Indoleamine 2,3-Dioxygenase 1. J.Med.Chem. V. 62 6705 2019.
ISSN: ISSN 0022-2623
PubMed: 31264862
DOI: 10.1021/ACS.JMEDCHEM.9B00662
Page generated: Wed Aug 7 04:04:52 2024

Last articles

F in 7QVZ
F in 7QVL
F in 7QV9
F in 7QSC
F in 7QTM
F in 7QTV
F in 7QU0
F in 7QRA
F in 7QRB
F in 7QRC
© Copyright 2008-2020 by atomistry.com
Home   |    Site Map   |    Copyright   |    Contact us   |    Privacy